<?xml version='1.0' encoding='utf-8'?>
<document id="27643859"><sentence text="Simultaneous determination of telmisartan and pitavastatin in rat plasma by UPLC-MS/MS: Application to pharmacokinetic interaction study."><entity charOffset="30-41" id="DDI-PubMed.27643859.s1.e0" text="telmisartan" /><entity charOffset="46-58" id="DDI-PubMed.27643859.s1.e1" text="pitavastatin" /><pair ddi="false" e1="DDI-PubMed.27643859.s1.e0" e2="DDI-PubMed.27643859.s1.e0" /><pair ddi="false" e1="DDI-PubMed.27643859.s1.e0" e2="DDI-PubMed.27643859.s1.e1" /></sentence><sentence text="To investigate the pharmacokinetic (PK) interaction between telmisartan (Tel) and pitavastatin (Pit), a rapid and sensitive ultra performance liquid chromatography-tandem mass spectrometric assay method had been successfully established and fully validated for the simultaneous quantification of Tel and Pit in rat plasma"><entity charOffset="60-71" id="DDI-PubMed.27643859.s2.e0" text="telmisartan" /><entity charOffset="73-76" id="DDI-PubMed.27643859.s2.e1" text="Tel" /><entity charOffset="82-94" id="DDI-PubMed.27643859.s2.e2" text="pitavastatin" /><entity charOffset="296-307" id="DDI-PubMed.27643859.s2.e3" text="Tel" /><pair ddi="false" e1="DDI-PubMed.27643859.s2.e0" e2="DDI-PubMed.27643859.s2.e0" /><pair ddi="false" e1="DDI-PubMed.27643859.s2.e0" e2="DDI-PubMed.27643859.s2.e1" /><pair ddi="false" e1="DDI-PubMed.27643859.s2.e0" e2="DDI-PubMed.27643859.s2.e2" /><pair ddi="false" e1="DDI-PubMed.27643859.s2.e0" e2="DDI-PubMed.27643859.s2.e3" /><pair ddi="false" e1="DDI-PubMed.27643859.s2.e1" e2="DDI-PubMed.27643859.s2.e1" /><pair ddi="false" e1="DDI-PubMed.27643859.s2.e1" e2="DDI-PubMed.27643859.s2.e2" /><pair ddi="false" e1="DDI-PubMed.27643859.s2.e1" e2="DDI-PubMed.27643859.s2.e3" /><pair ddi="false" e1="DDI-PubMed.27643859.s2.e2" e2="DDI-PubMed.27643859.s2.e2" /><pair ddi="false" e1="DDI-PubMed.27643859.s2.e2" e2="DDI-PubMed.27643859.s2.e3" /></sentence><sentence text=" A simple protein precipitation procedure was adopted for the sample preparation with satisfactory extraction recovery for both analytes and the internal standard" /><sentence text=" The samples were chromatographed on an Inertsil ODS-3 C18 column (100mm×2" /><sentence text="1mm, 2μm) using a mixture of acetonitrile and 10mM ammonium acetate containing 0"><entity charOffset="29-41" id="DDI-PubMed.27643859.s5.e0" text="acetonitrile" /><entity charOffset="51-67" id="DDI-PubMed.27643859.s5.e1" text="ammonium acetate" /><pair ddi="false" e1="DDI-PubMed.27643859.s5.e0" e2="DDI-PubMed.27643859.s5.e0" /><pair ddi="false" e1="DDI-PubMed.27643859.s5.e0" e2="DDI-PubMed.27643859.s5.e1" /></sentence><sentence text="1% formic acid (60: 40, v/v) as the mobile phase at a flow rate of 0"><entity charOffset="3-14" id="DDI-PubMed.27643859.s6.e0" text="formic acid" /></sentence><sentence text="4mL/min" /><sentence text=" The calibration curves obtained were linear (r&gt;0" /><sentence text="99) over the concentration range of 2-200ng/mL for Tel and 1-100ng/mL for Pit, respectively"><entity charOffset="51-61" id="DDI-PubMed.27643859.s9.e0" text="Tel" /></sentence><sentence text=" The validated method was successfully applied to the PK study and the data did not reveal any evidence for the potential drug-drug interaction (DDI) between Tel and Pit"><entity charOffset="158-160" id="DDI-PubMed.27643859.s10.e0" text="Tel" /></sentence><sentence text=" This information would provide the evidence for clinical rational use of Tel and Pit, and this study might be applied in therapeutic drug monitoring in patients receiving Tel/Pit combinations or single drug"><entity charOffset="74-76" id="DDI-PubMed.27643859.s11.e0" text="Tel" /><entity charOffset="172-174" id="DDI-PubMed.27643859.s11.e1" text="Tel" /><pair ddi="false" e1="DDI-PubMed.27643859.s11.e0" e2="DDI-PubMed.27643859.s11.e0" /><pair ddi="false" e1="DDI-PubMed.27643859.s11.e0" e2="DDI-PubMed.27643859.s11.e1" /></sentence><sentence text="" /></document>